Tuberculosis is a leading cause of infectious disease death worldwide, particularly in some of the countries where U.S. troops often deploy. Commonly known as TB, it can be difficult to detect among service members returning from high-risk locations.
Current TB tests have their limitations. Some tests take days or weeks to get results, some have poor sensitivity, and still others are expensive and require a sophisticated lab facility.
That prompted the Air Force to seek a practical and reliable alternative.
With the backing of an Air Force Small Business Innovation Research (SBIR) contract, Michigan-based nanoRETE Inc. worked to develop an improved diagnostic platform for TB testing. The company’s concept follows the same principle as the latest commercial methods—a hypersensitivity based on prior exposure—but is designed to employ multiple biomarkers to determine a person’s infection status.
Solid-State Amplifier/Transmitter Replacements for Traveling Wave Tube (TWT) Technology
Smart and Fast: New Tech Speeds HCF Qualification of New Materials
Fast High Resolution, High Contrast Microfocus X-ray Computed Tomography Reconstruction Algorithms for ICBM Components
High-Value Experiential Training & Education Rapid Process/Model Prototype
A Shared Reasoning Environment for the Acquisition Life Cycle
Lasers Enable the Latest in High-Resolution 3D Image Sensors
SoluStat – The Next Generation Diagnostic for Aerospace Chemical Stripping Solutions
Innovative All-fiber Components Improve High Power Fiber Laser Systems for DoD
Robots Aiding the Raptor to Fly to Combat Readiness Faster
Rapid, Local Characterization of the Fatigue Growth Crack Behavior